The potential for captive-bred specific pathogen free (SPF)monkeys provides a much cleaner and safer animal with reduced research interference.
Biocontainment and bioexclusion D.rW J~hite (Charles River Laboratories, USA) BIOc~ntal~ment and bioexclusion are very different sItuatIOns (one keeps things in, the other keeps them outl and you cannot do both in housing animals. It is important to think at the outset which is required in a given situation and how to provide what is needed. Containment often conflicts with animals' needs. However good are the physical barriers of containment or exclusion people are always the weak link in the chain. ' Barriers for containment or exclusion may be at the lev~l of a building or room. Alternatively, and a growmg trend, is to provide the barrier at the level of the cage. This 'microisolator' approach is currently the subject of much research. Interestingly 'smoke tests' show that filter cage tops seldom provide an ideal seal and high-efficiency particulate air filtration cannot be provided at this level.
Control of iatrogenic infections from surgical implants Mr A J Webb (Pfizer Central Research)
The causes of post-surgical infections were reviewed. Studies of incidence rates of such infections in human and veterinary surgery at hospitals where 'best practice' aseptic surgery was perfornled showed an inevitable infection rate of 2-4% for clean, uncontaminated wounds. The so.urce o~such infections is animal (or patient) WIth a hIgh correlation of organisms cultured from implant infections wiili the skin flora lin both human patients with implanted vascular catheters and animals with implants). Wound infection rates increase with the level of microbial contamination and nature of the procedure and classification systems such as that of the American College of Surgeons may be used to classify wounds and the resulting infection risk. The presence of implants is a risk factor in wound infection and good design, construction and use of suitable materials in surgical implants is a rational approach to reducing the probability of infection.
Use of totally implantable devices (e.g. vascular access ports, telemetry devices) is associated with lower rates of infection than where cables or catheters exit through the skin. 1988 , 1989 , Matsushima 1995 , Matsushima et al. 1996 , !ida et al. 1997 .We note that Professors Esaki and Okumoto have reported ilieir work elsewhere (Song et al. 1995 (Song et al. , 1996 (Song et al. , 1997 .However neither in their previous reports, nor in the recenp aper published in Laboratory Animals, was any reference made to our work. This omission will cause confusion in the scientific literature but also the history detailed above clearly indi~ates that the priority of the work is wiili Dr Matsushirna.
The discovery in members of the CXS RI strains, the map location on chromosome 14, and the clinical manifestation, all favour the conclusion that the rIc and lr2 are the same, unless Song e~al. can provide vigorous evidence for significant dIfferences that make these two distinct mutations. The potential for captive-bred specific pathogen free (SPF)monkeys provides a much cleaner and safer animal with reduced research interference.
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Control of iatrogenic infections from surgical implants Mr A J Webb (Pfizer Central Research)
Use of totally implantable devices (e.g. vascular access ports, telemetry devices) is associated with lower rates of infection than where cables or catheters exit through the skin. (Song et al. 1995 (Song et al. , 1996 (Song et al. , 1997 .However neither in their previous reports, nor in the recenp aper published in Laboratory Animals, was any reference made to our work. This omission will cause confusion in the scientific literature but also the history detailed above clearly indi~ates that the priority of the work is wiili Dr Matsushirna.
The discovery in members of the CXS RI strains, the map location on chromosome 14, and the clinical manifestation, all favour the conclusion that the rIc and lr2 are the same, unless Song e~al. can provide vigorous evidence for significant dIfferences that make these two distinct mutations. Fourthly, the oral presentations on the mutant by Dr Matsushima's group in 1988 and 1989 (Societas Ophthalmological Japonica) were made in our absence. After those presentations, Drs Hiai and Matsushima did not make any public presentation or publication of their findings until they submitted pathogenesis and genetic mode of RLC mouse (Experimental Eye Research, Vol. 64, 1997) , and mapping on chromosome 14 (Genomics, Vol. 36, 1996) . Therefore, it was impossible to know the detailed information about similarities between lr2 and rIc when we submitted our results to Laboratory Animals in 1996 (see below).
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Finally, we orally presented our research on lr2 at the 1995 Annual Meeting of the Japanese Association of Laboratory Animal Science (JALASI.We talked about the pathogenesis and genetic mode of our lr2 mice, and suggested the locus of the mutant was on chromosome 14. The content of the presentation was subsequently submitted to Laboratory Animals on 10 July 1996 and we were notified of its acceptance on 12 December 1996. Similar pathology and genetics of rIc were published in 1997 (Experimental Eye Research, Vol. 64)-meaning that it was not possible for us to refer to it in our manuscript in 1996.
. In summary, it was impossible to refer to Dr Matsushima's mutant in our manuscript before we knew the detailed information about it. Since rlc and lr2 mutants were derived from different mouse strains independently in different places, and researches were also carried out independently, we believe it is more reasonable to use two different mutant names until it is clearly proven that they are exactly the same mutant. Please bear in mind that the 'Rules and Guidelines for Gene Nomenclature, 1994' say that 'A proposed new symbol must not duplicate one already used for another locus ... (1.1.1-6)'. However, the pathological similarities and the close locations of the mutant gene(s) are certainly of great interest for further research. 
